Literature DB >> 7141198

Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan.

J L Sung, D S Chen, M Y Lai, T H Wang, C Y Wang, J Y Yü, C Y Lee.   

Abstract

Two hundred and twenty two asymptomatic carriers of hepatis B surface antigen (HBsAg) with age between 4 months and 68 years, 172 healthy persons with antibody to HBsAg (anti-HBs) and 85 healthy persons seronegative for both HBsAg and anti-HBs were studied by double immunodiffusion for the evaluation of the meaning of hepatitis B e antigen (HBeAg) and its antibody (anti-HBe). In 222 asymptomatic carriers, HBeAg was detected in 32.4% and anti-HBe in 31.5%. The geometric titer of HBsAg was 1:2159 in the HBeAg positive and 1:149 in the anti-HBe positive persons. Frequencies of HBeAg and anti-HBe in asymptomatic carriers of HBsAg correlated closely with age. The highest frequency of HBeAg was found in the first decade in 64% decreasing steadily to 20.8% in the fourth and then suddenly down to 4.1% in the fifth decade. A reverse trend was observed in anti-HBe frequency. From our analysis, it is likely that the high frequency of HBeAg in serum of Chinese, especially in females of fertile age, might be an important contributing factor for the high rates of hepatitis B virus (HBV) infection and HBsAg carrier in Taiwan. The presence of HBeAg/anti-HBe system is not only a market of infectivity and prognosis but also a chronologic marker of HBV infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141198     DOI: 10.1007/bf02774580

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  25 in total

1.  Vertical transmission of hepatitis B antigen in Taiwan.

Authors:  C E Stevens; R P Beasley; J Tsui; W C Lee
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

2.  Hepatitis B e antigen and antibody activity in hepatitis B virus infection.

Authors:  M L Tiku; G M Makhdoomi; K R Beutner; N Nath; P L Ogra
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

3.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

4.  Factors influencing neonatal infection by hepatitis B virus.

Authors:  I L Schweitzer; J W Mosley; M Ashcaval; V M Edwards; L B Overby
Journal:  Gastroenterology       Date:  1973-08       Impact factor: 22.682

5.  Hepatitis-associated antigen and antibody in Taiwan.

Authors:  P L Shih; C K Chang; J L Sung
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1971-12-28

6.  Transplacental transmission of hepatitis-B virus by symptom-free chronic carrier mothers.

Authors:  G Papaevangelou; J Hoofnagle; J Kremastinou
Journal:  Lancet       Date:  1974-09-28       Impact factor: 79.321

7.  Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

Authors:  N Eleftheriou; H C Thomas; J Heathcote; S Sherlock
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

8.  Frequency of Australia antigen in blood donors in Singapore.

Authors:  M J Simons; E H Yap; Y W Ong; K Okochi; M Mayumi; K Nishioka
Journal:  Am J Dis Child       Date:  1972-04

9.  Studies of the "e" antigen in acute and chronic hepatitis.

Authors:  J L Smith; B L Murphy; M O Auslander; J E Maynard; S S Schalm; W H Summerskill; G L Gitnick
Journal:  Gastroenterology       Date:  1976-08       Impact factor: 22.682

10.  Detection of e antigen and antibody: correlations with hapatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections.

Authors:  C G Trepo; L O Magnius; R A Schaefer; A M Prince
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.